Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

Alping P, Öberg Sysojev A, Piehl F, Frisell T

Open source

DOI
10.1111/ene.70656
Published
2026 Jun
Container
European journal of neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ene.70656,
  title = {Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.},
  author = {Alping P and Öberg Sysojev A and Piehl F and Frisell T},
  year = {2026},
  journal = {European journal of neurology},
  doi = {10.1111/ene.70656},
  url = {https://doi.org/10.1111/ene.70656}
}

RIS

TY  - JOUR
TI  - Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.
AU  - Alping P
AU  - Öberg Sysojev A
AU  - Piehl F
AU  - Frisell T
PY  - 2026
JO  - European journal of neurology
DO  - 10.1111/ene.70656
UR  - https://doi.org/10.1111/ene.70656
ER  - 

APA

P, A., A, Ö. S., F, P., & T, F. (2026). Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.. European journal of neurology. https://doi.org/10.1111/ene.70656

Source records